Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
July 20, 2017Yelena Janjigian, MD: Metastatic gastric cancer: What are the indications and what is the impact of angiogenesis inhibitorsWebcast: ESMO 19th World Congress on Gastrointestinal Cancer11 minPlay
July 20, 2017Julien Taieb, MD: Metastatic gastric cancer: What are the indications and what is the impact of stem-cell inhibitionWebcast: ESMO 19th World Congress on Gastrointestinal Cancer9 minPlay
July 20, 2017Michel Ducreux, MD, PhD: Hepatocellular Carcinoma Debate - Logoregional treatment firstWebcast: ESMO 19th World Congress on Gastrointestinal Cancer13 minPlay
July 20, 2017Franck Carbonnel, MD: IBD-related GI cancers: Are they different?Webcast: ESMO 19th World Congress on Gastrointestinal Cancer16 minPlay
July 20, 2017Pierre Laurent-Puig, MD, PhD: How to do MSI testing?Webcast: ESMO 19th World Congress on Gastrointestinal Cancer22 minPlay
July 20, 2017Judith Balmaña, MD, PhD: When and how to do BRCA testing in GI cancer and what are the implications?Webcast: ESMO 19th World Congress on Gastrointestinal Cancer21 minPlay
July 20, 2017Aurel Perren, MD: Pathological classification of NETWebcast: ESMO 19th World Congress on Gastrointestinal Cancer17 minPlay
July 20, 2017Rachel Riechelmann, MD, PhD, Ramon Salazar, MD and Jonathan Strosberg, MD: Controversy debate: Targeted agents versus PRRT in NET - Case scenariosWebcast: ESMO 19th World Congress on Gastrointestinal Cancer25 minPlay
July 20, 2017Jaroslaw Regula, MD, PhD: Recommendations for surveillance of adenomasWebcast: ESMO 19th World Congress on Gastrointestinal Cancer20 minPlay
July 20, 2017Nadir Arber, MD, MHA: Can we improve screening methods of colorectal cancer?Webcast: ESMO 19th World Congress on Gastrointestinal Cancer22 minPlay